108 related articles for article (PubMed ID: 7384752)
21. Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis.
Wolinsky JS; Waxham MN; Server AC
J Virol; 1985 Mar; 53(3):727-34. PubMed ID: 3973964
[TBL] [Abstract][Full Text] [Related]
22. Involvement of fusion activity of ultraviolet light-inactivated Sendai virus in formation of target antigens recognized by cytotoxic T cells.
Sugamura K; Shimizu K; Bach FH
J Exp Med; 1978 Jul; 148(1):276-87. PubMed ID: 78960
[TBL] [Abstract][Full Text] [Related]
23. Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.
Santoli D; Trinchieri G; Lief FS
J Immunol; 1978 Aug; 121(2):526-31. PubMed ID: 681748
[TBL] [Abstract][Full Text] [Related]
24. The participation of antibody in spontaneous and antibody-dependent cell-mediated cytotoxicity in the pig.
Cepica A; Derbyshire JB
J Comp Pathol; 1987 Nov; 97(6):709-13. PubMed ID: 3443694
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin-independent natural cytotoxicity of Fc receptor-bearing human blood lymphocytes to mumps virus-infected target cells.
Härfast B; Andersson T; Perlmann P
J Immunol; 1978 Aug; 121(2):755-61. PubMed ID: 308078
[No Abstract] [Full Text] [Related]
26. Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.
Perrin LH; Zinkernagel RM; Oldstone MB
J Exp Med; 1977 Oct; 146(4):949-69. PubMed ID: 302316
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of cytotoxicity of human peripheral blood lymphocytes by interferon.
Kato T; Minagawa T
Microbiol Immunol; 1981; 25(8):837-45. PubMed ID: 6169978
[TBL] [Abstract][Full Text] [Related]
28. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
Brier AM; Chess L; Schlossman SF
J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes.
Greenberg SB; Criswell BS; Six HR; Couch RB
J Immunol; 1977 Dec; 119(6):2100-6. PubMed ID: 334984
[TBL] [Abstract][Full Text] [Related]
30. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.
Adhikary D; Behrends U; Moosmann A; Witter K; Bornkamm GW; Mautner J
J Exp Med; 2006 Apr; 203(4):995-1006. PubMed ID: 16549597
[TBL] [Abstract][Full Text] [Related]
31. HLA restriction of secondary mumps-specific cytotoxic T lymphocytes.
Kress HG; Kreth HW
J Immunol; 1982 Aug; 129(2):844-9. PubMed ID: 6177787
[TBL] [Abstract][Full Text] [Related]
32. Interactions between human lymphocytes and paramyxovirus-infected cells: adsorption and cytotoxicity.
Härfast B; Andersson T; Stejskal V; Perlmann P
J Immunol; 1977 Apr; 118(4):1132-7. PubMed ID: 300397
[TBL] [Abstract][Full Text] [Related]
33. Immunological properties of purified mumps virus glycoproteins.
Orvell C
J Gen Virol; 1978 Dec; 41(3):517-26. PubMed ID: 570595
[No Abstract] [Full Text] [Related]
34. Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.
Perrin LH; Joseph BS; Cooper NR; Oldstone MB
J Exp Med; 1976 May; 143(5):1027-41. PubMed ID: 177712
[TBL] [Abstract][Full Text] [Related]
35. The response of human lymphocyte subpopulations to measles, mumps, and vaccinia viral antigens.
McFarland HF; Pedone CA; Mingioli ES; McFarlin DE
J Immunol; 1980 Jul; 125(1):221-5. PubMed ID: 6966650
[TBL] [Abstract][Full Text] [Related]
36. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
[TBL] [Abstract][Full Text] [Related]
37. Cell-mediated immune response to mumps virus infection in man.
Chiba Y; Dzierba JL; Morag A; Ogra PL
J Immunol; 1976 Jan; 116(1):12-5. PubMed ID: 1245735
[TBL] [Abstract][Full Text] [Related]
38. Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro.
Klaesson S; Ringdén O; Markling L; Remberger M; Lundkvist I
Scand J Immunol; 1993 Nov; 38(5):477-84. PubMed ID: 8235451
[TBL] [Abstract][Full Text] [Related]
39. Naturally occurring lymphocyte-mediated immunity to endogenous type-C virus in the mouse. Blocking of the lymphocyte reactivity with antisera to the virus.
Kende M; Hill R; Dinowitz M; Stephenson JR; Kelloff GJ
J Exp Med; 1979 Feb; 149(2):358-71. PubMed ID: 216767
[TBL] [Abstract][Full Text] [Related]
40. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
